Immix Biopharma, Inc. (IMMX)
7.48
-0.36
(-4.59%)
USD |
NASDAQ |
Nov 16, 16:00
7.49
+0.01
(+0.13%)
After-Hours: 20:00
Immix Biopharma Total Assets (Quarterly) : 345.95M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 345.95M |
| June 30, 2026 | 239.11M |
| March 31, 2026 | 95.82M |
| December 31, 2025 | 104.84M |
| September 30, 2025 | 20.08M |
| June 30, 2025 | 15.64M |
| March 31, 2025 | 19.89M |
| December 31, 2024 | 22.95M |
| September 30, 2024 | 25.14M |
| June 30, 2024 | 28.84M |
| March 31, 2024 | 34.35M |
| Date | Value |
|---|---|
| December 31, 2023 | 19.93M |
| September 30, 2023 | 22.47M |
| June 30, 2023 | 15.57M |
| March 31, 2023 | 13.21M |
| December 31, 2022 | 14.91M |
| September 30, 2022 | 17.40M |
| June 30, 2022 | 19.09M |
| March 31, 2022 | 20.02M |
| December 31, 2021 | 18.19M |
| September 30, 2021 | 0.4953M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
| Arrowhead Pharmaceuticals, Inc. | 1.810B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.89M |
| Shareholders Equity (Quarterly) | 335.06M |
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 33.72 |
| Net Debt Paydown Yield | 0.00% |